Every Form 4 that Arteris, Inc. (AIP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AIP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AIP filings page.
Insider sale to cover taxes by Arteris CFO. On 10/02/2025, Nicholas B. Hawkins, the company’s Vice President and Chief Financial Officer, reported three open-market sales of 3,887 shares of Arteris, Inc. (AIP) at an effective price of $10.9208 per share. The three disposals were for 891, 1,508 and 1,488 shares and reduced the reporting person’s direct holdings in stages from 103,007 shares to 100,011 shares following the transactions.
The filing states the shares were sold to satisfy the reporting person’s tax liability triggered by the release of restricted stock units. The Form 4 was signed by an attorney-in-fact on 10/06/2025. No derivative transactions or other types of securities were reported.
Arteris, Inc. director Joachim Kunkel reported receipt of 1,496 shares of common stock as fully vested restricted stock on 10/05/2025. The shares were issued as retainer fees elected in lieu of cash and the reporting person elected to defer receipt; the transaction price is reported as $0.00.
Following the transaction, the reporting person beneficially owns 67,818 shares. The Form 4 was signed by an attorney-in-fact on 10/06/2025 and indicates the filing is by one reporting person and that the reporting person is a director.
Paul L. Alpern, Vice President and General Counsel of Arteris, Inc. (AIP), reported transactions dated 10/01/2025 executed under a 10b5-1 trading plan adopted on June 5, 2025. The reporting person acquired 5,000 shares (transaction code M) at an effective price of $0.56 and sold 5,000 shares (transaction code S) at a weighted average price of $10.3089, with sale prices ranging from $10.16 to $10.51. After the transactions, the report shows 73,587 shares beneficially owned as to the non-derivative holdings and 85,000 shares when including derivative securities. The derivative shown is an option with a $0.56 exercise price exercisable beginning 10/01/2025 and expiring 10/23/2029. The filing is signed and dated 10/03/2025.
Paul L. Alpern, who is listed as a director and as an officer (VP and General Counsel) of Arteris, Inc. (AIP), reported a set of transactions dated 09/15/2025 made pursuant to a 10b5-1 trading plan adopted June 5, 2025. The filing shows an acquisition of 10,000 common shares at a $0.56 exercise/conversion price and a simultaneous sale of 10,000 common shares at a weighted average price of $8.8805 (sales executed across $8.73–$8.97). After these transactions, the reporting person’s direct beneficial ownership in common stock was reported as 73,587 shares. The derivative table shows the reporting person holds options exercisable 09/15/2025 with a $0.56 strike for 10,000 underlying shares and reports 90,000 derivative securities beneficially owned following the reported transactions. The filing is signed 09/17/2025.